Mode
Text Size
Log in / Sign up

Genetically predicted obstructive sleep apnea liability associated with increased myocardial infarction risk in Mendelian randomization analysisYour Sleep Apnea May Be a Direct Threat to Your Heart

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that genetically predicted OSA liability is associated with increased MI risk, but this association is largely mediated by BMI and blood pressure.

This Mendelian randomization analysis evaluated the causal relationship between genetically predicted liability to obstructive sleep apnea (OSA) and the risk of myocardial infarction (MI). The study utilized genetic instruments to assess OSA liability, finding an odds ratio of 1.0024 per log-OR increase in liability (95% CI: 1.0010-1.0039; P=0.001). This suggests a potential causal link, though the effect size per unit increase is very small.

mediation analysis revealed that body mass index (BMI) was the strongest mediator, explaining 35.94% of the observed association (P=0.030). In contrast, systolic blood pressure showed minimal mediation, accounting for only 0.28% of the association (P=0.678). When the model was adjusted for both BMI and systolic blood pressure, the direct association between OSA and MI was attenuated, with a P-value of 0.156.

Further modeling including atrial fibrillation demonstrated that OSA had only a marginal direct effect (P=0.050), whereas atrial fibrillation remained independently associated with MI (P=0.004). The analysis also found no evidence that MI influenced OSA risk, ruling out reverse causality. Safety data, adverse events, and discontinuations were not reported. The study limitations include the inherent constraints of Mendelian randomization designs and the attenuation of the primary association after accounting for established cardiometabolic risk factors like obesity and hypertension.

Obstructive sleep apnea is incredibly common. It happens when the throat muscles relax during sleep, blocking the airway. Breathing stops and starts repeatedly throughout the night.

This starves the body of oxygen.

It affects nearly 1 billion adults worldwide. Many don’t even know they have it. They just live with crushing fatigue, morning headaches, and poor concentration.

The frustration has always been in the “chicken or egg” problem. People with sleep apnea often also have high blood pressure, obesity, and diabetes. These are all major risk factors for heart disease.

So, is the apnea itself damaging the heart? Or is it just a bystander?

This question has left patients and doctors wondering how urgently to treat the apnea beyond just improving sleep and energy.

The Surprising Shift

The old thinking was cautious. It said, “Sleep apnea is a marker of poor health, and we should manage all the other risks like weight and blood pressure.”

The new evidence demands a shift.

This study says sleep apnea is not just a marker. It is an active, independent player in heart attack risk. It has a direct, causal role.

But here’s the twist: it doesn’t work alone.

How Your Body Connects the Dots

Think of your heart’s health like a domino chain. For a long time, doctors thought sleep apnea tipped the first domino simply by raising blood pressure every time you struggled to breathe.

This new research reveals a different setup.

It shows that obesity (high body mass index, or BMI) is a massive, central domino. It explains over a third of the link between apnea and heart attack. The strain of carrying extra weight worsens apnea, and the metabolic havoc of obesity harms the heart.

Here’s where it gets interesting.

The study found that the classic culprit—high blood pressure—played a surprisingly small direct role. Instead, a different dangerous domino appeared: atrial fibrillation (AFib).

AFib is a common heart rhythm disorder where the heart beats irregularly. Sleep apnea creates the perfect storm of stress and oxygen swings that can trigger AFib. And AFib is a well-known gateway to more severe heart problems, including heart attacks.

A Snapshot of the Science

To get past the “chicken or egg” dilemma, scientists used a clever method called Mendelian randomization. They used genetic data from hundreds of thousands of people in large biobanks.

Your genes are set at birth. So, by studying people genetically predisposed to sleep apnea, researchers could see if they also had a higher risk of heart attack—without the confusion of their later-life habits or other diseases.

This method is like a natural, lifelong experiment.

The core finding was stark. A person’s genetic tendency for obstructive sleep apnea directly increased their genetic risk for a heart attack.

When the scientists dug deeper, the story became more detailed. Adjusting for obesity and blood pressure significantly weakened the link. This means these shared factors are major co-conspirators.

But there’s a catch.

In a final, crucial model, even after accounting for key factors, sleep apnea’s direct link to heart attack risk still lingered. And the data pointed strongly to atrial fibrillation (AFib) as a critical middleman in this dangerous relationship.

This type of study is considered some of the strongest evidence available for proving cause and effect in human health. It moves the connection between sleep apnea and heart attacks from a concerning observation to a biological reality.

The highlight on AFib is a key insight. It suggests that the heart attack risk from apnea isn't only about slow, silent damage from high blood pressure. It may also involve sudden, electrical chaos in the heart's rhythm.

This is not a call to panic. It is a call to action.

If you snore loudly, wake up gasping, or feel unbearably tired during the day, talk to your doctor. A sleep study can diagnose apnea. This research strengthens the case that treating sleep apnea isn’t just about getting better sleep—it’s a critical part of protecting your long-term heart health.

Effective treatments like CPAP (a machine that keeps your airway open with gentle air pressure) do more than improve rest. They stabilize oxygen levels and may help lower the strain on your heart and cardiovascular system.

The Limits of the Findings

This study has limitations. It used genetic data, which shows lifelong risk, not short-term effects. It can’t tell us exactly how much treating apnea reduces heart attack risk in an individual person. More clinical trials are needed to answer that.

The path is clear. Future research needs to focus on the specific biological highway from apnea to AFib to heart attack. Doctors will increasingly look at sleep apnea as a modifiable risk factor for heart disease, similar to high cholesterol.

The timeline for this knowledge to become standard care is already shortening. It reinforces current medical guidelines that take sleep apnea seriously.

For anyone with the condition, the message is empowering. Treating your sleep apnea is a powerful step you can take for your heart’s future.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
BACKGROUND: Observational studies have suggested an association between obstructive sleep apnea (OSA) and myocardial infarction (MI), but whether this relationship is causal or largely reflects shared risk factors remains unclear. METHODS AND RESULTS: We performed a 2-sample Mendelian randomization (MR) analysis to evaluate the causal effect of OSA on MI. Summary statistics for OSA were obtained from FinnGen, and MI data were obtained from the UK Biobank, with external validation using CARDIoGRAMplusC4D. Mediation MR was used to assess 13 potential mediators, and a 6-step multivariable MR framework was applied to estimate the direct effect of OSA after sequential adjustment for potential confounders. Reverse MR was conducted to test possible reverse causality. Genetically predicted OSA liability was associated with increased MI risk (odds ratio [OR] per log-OR increase, 1.0024 [95% CI, 1.0010-1.0039]; P=0.001). Body mass index (BMI) was the strongest mediator, explaining 35.94% of the association (P=0.030), whereas systolic blood pressure (SBP) showed minimal mediation (0.28%; P=0.678). In stepwise multivariable MR, the OSA-MI association was attenuated after adjustment for BMI and SBP (P=0.156), suggesting partial confounding by shared cardiometabolic risk. In a model including SBP and atrial fibrillation (AF), AF remained independently associated with MI (P=0.004), whereas OSA showed only a marginal direct effect (P=0.050). Reverse MR found no evidence that MI influenced OSA risk. CONCLUSIONS: These findings support a causal association between OSA and MI and suggest that this relationship may be mediated in part through obesity-related and arrhythmia-related pathways. AF may represent an important intermediate component of OSA-related cardiovascular risk beyond traditional hemodynamic factors. Keywords: obstructive sleep apnea; myocardial infarction; Mendelian randomization; mediation analysis; obesity.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.